In the News
Flatiron co-authored a piece with DATA-CAN highlighting the crucial role of patient voices in improving the quality and accessibility of RWD in cancer
The BMJ Opinion
Read more
Quick facts
- We work with >280 community cancer centers & seven major academic cancer centers across the U.S., as well as 20+ top global developers of oncology therapeutics.
- Of almost 3 million patient records available for research in our network, 80% are from community practices, 20% are from academic cancer centers.
- Our 2,500+ employees include software engineers, data scientists, biostatisticians, epidemiologists, health professionals and other experts.
- We partner with the National Cancer Institute, the U.S. Food & Drug Administration, the National Comprehensive Cancer Network® and others, and we are a founding member of the RWE Alliance.
- Insights from our real-world data have helped expand treatment alternatives for people with gastric, esophageal and breast cancer, and illuminated the impact of healthcare policy on racial disparities in time to treatment.
- Flatiron Health was founded in 2012 and has been an independent affiliate of the Roche Group since 2018.
Press Releases
